Upon univariate analysis of the hematological parameters with tumor staging, nodal involvement, and tissue survivin protein concentration, we found that with regards to tumor staging, absolute lymphocyte count and absolute platelet count were found to be elevated among T1–T2 stage patients, compared to T3–T4 stage. Here, BIRC5 is linked to neoplasm.